相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
Igor Letovanec et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer
Anne McLeer-Florin et al.
LUNG CANCER (2018)
Response to crizotinib in advanced &ITALK&IT-rearranged non-small cell lung cancers with different &ITALK&IT-fusion variants
Yan Li et al.
LUNG CANCER (2018)
Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer?
Anthonie J. van der Wekken et al.
JOURNAL OF THORACIC DISEASE (2018)
RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance
Claudia Vollbrecht et al.
BMC CANCER (2018)
ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?
Florian Cabillic et al.
ESMO OPEN (2018)
Detection of ALK rearrangements in 4002 Russian patients: The utility of different diagnostic approaches
Irina Demidova et al.
LUNG CANCER (2017)
EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients
Sarah R. Sabir et al.
CANCERS (2017)
Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches
Julie A. Vendrell et al.
SCIENTIFIC REPORTS (2017)
Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer
A. J. van der Wekken et al.
CLINICAL CANCER RESEARCH (2017)
The role of the ALK receptor in cancer biology
B. Hallberg et al.
ANNALS OF ONCOLOGY (2016)
A new look at the ALK gene in cancer: copy number gain and amplification
Federica Zito Marino et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas
Esther Conde et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer
Tatsuya Yoshida et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma
Jin Sung Jang et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Testing for ROS1 in non-small cell lung cancer: a review with recommendations
Lukas Bubendorf et al.
VIRCHOWS ARCHIV (2016)
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer
Anna F. Farago et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
ALK FISH and IHC You Cannot Have One without the Other
Yasushi Yatabe
JOURNAL OF THORACIC ONCOLOGY (2015)
Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended
Spasenija Savic et al.
LUNG CANCER (2015)
Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer
Marina Pekar-Zlotin et al.
ONCOLOGIST (2015)
Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies
M. I. Ilie et al.
ANNALS OF ONCOLOGY (2015)
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
Takashi Nakaoku et al.
CLINICAL CANCER RESEARCH (2014)
Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
Yoon Jin Cha et al.
PLOS ONE (2014)
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Neal I. Lindeman et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
Alexander Drilon et al.
CANCER DISCOVERY (2013)
Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes
Katsuyuki Shiroguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
Erik Thunnissen et al.
VIRCHOWS ARCHIV (2012)
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Jonathan Weiss et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2009)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
分享论文
